The Global Fund plays a significant role in global markets for medicines and technologies that prevent, diagnose or treat HIV/AIDS, TB and malaria. We remain committed to continuing to play an active, deliberate and strategic role in shaping markets to maximize access to health products and improve health outcomes for people affected by the diseases.
Our Market Shaping Strategy (2016-2021) defines how our partnership can contribute to health outcomes by leveraging our position to facilitate healthier global markets for health products – today and in the future. These efforts are guided by five principles, to be:
Guiding our market shaping efforts are our strategic objectives:
The strategy details our vision, principles, strategic objectives and more:
Among several cross-cutting initiatives aimed at increasing access to health products, the Pooled Procurement Mechanism and wambo.org are two tools that the Global Fund utilizes to deliver on the Market Shaping Strategy.
Efforts to date have yielded significant impact. Additional information by health product category is available in our Sourcing & Procurement of Health Products section.
We are engaging with technical and development partners to develop a road map to further operationalize efforts to deliver on the Market Shaping Strategy and create even greater value for the Global Fund, partners and people living with or affected by the diseases. Our vision for the future is to ensure healthy markets, sustainable supply and increased country capacity.
The Global Fund regularly hosts a Sourcing Strategic Review, bringing together thought leaders and partners in global public health. Participants include Unitaid, the Clinton Health Access Initiative (CHAI), the Bill & Melinda Gates Foundation, the U.K. Department for International Development (DFID), the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the U.S. President’s Malaria Initiative (PMI), large country procurers and other stakeholders.
These collaborative meetings facilitate improved sharing and coordination among the Global Fund and partners, resulting in increased strategic capability in increasing access to medicines and health commodities for our implementing partners and the populations they serve.